IBRX$8.295.15%-0.45
After Hours: 8.290.00 0.00%
Immunitybio Inc (IBRX)
Date: 2026-10-30 16:00O: 8.48H: 8.73L: 8.12C: 8.29Vol: 8.909M
Immunitybio Inc stock is traded at $8.29, with a volume of 8,909,180. It is down -5.15% in the last 24 hours and down -12.18% over the past month. ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
Previous Close:
$8.74
Open:
$8.48
24h Volume:
8,909,180
Relative Volume:
0.82
Market Cap:
$8.79B
Revenue:
$140.98M
Net Income/Loss:
-$854.60M
P/E Ratio:
-
EPS:
-$0.854
Net Cash Flow:
-$299.31M
1W Performance:
+0.85%
1M Performance:
-12.18%
6M Performance:
+16.76%
1Y Performance:
+251.27%
1-Day Range:
$8.12$8.73
1-Week Range:
$7.75$8.94
52-Week Range:
$1.95$12.43
Immunitybio Inc Stock (IBRX) Company Profile
Name
Immunitybio IncSector
HealthcareIndustry
BiotechnologyPhone
(844) 696-5235Address
3530 JOHN HOPKINS COURT, SAN DIEGO, USACompare IBRX vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBRX Immunitybio Inc | $8.29 | $8.79B | $140.98M | -$854.60M | -$299.31M | -$0.854 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
Immunitybio Inc Stock (IBRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Immunitybio Inc Stock (IBRX) Insider Trading
- Simon Barry J.Oct 05 '26Officer
- Transaction
- Proposed Sale
- Cost
- $13.67
- #Shares
- 560,000
- Value ($)
- 7,657,760
- #Shares Total
- 0
- CHERYL COHENOct 02 '26Director
- Transaction
- Proposed Sale
- Cost
- $9.28
- #Shares
- 81,056
- Value ($)
- 752,200
- #Shares Total
- 0
- Cohen CherylOct 02 '26Director
- Transaction
- Option Exercise
- Cost
- $2.98
- #Shares
- 55,979
- Value ($)
- 166,817
- #Shares Total
- 181,365
- Cohen CherylOct 02 '26Director
- Transaction
- Sale
- Cost
- $10.50
- #Shares
- 81,056
- Value ($)
- 851,088
- #Shares Total
- 100,309
- CHERYL L COHENJul 02 '26Officer
- Transaction
- Proposed Sale
- Cost
- $9.20
- #Shares
- 131,210
- Value ($)
- 1,207,132
- #Shares Total
- 0
- Cohen CherylJul 02 '26Director
- Transaction
- Option Exercise
- Cost
- $2.98
- #Shares
- 55,979
- Value ($)
- 166,817
- #Shares Total
- 256,596
- Cohen CherylJul 02 '26Director
- Transaction
- Sale
- Cost
- $9.50
- #Shares
- 131,210
- Value ($)
- 1,246,941
- #Shares Total
- 125,386
- Selecky ChristobelJul 01 '26Director
- Transaction
- Sale
- Cost
- $9.02
- #Shares
- 159,478
- Value ($)
- 1,439,066
- #Shares Total
- 0
- CHRISTOBEL SELECKYJul 01 '26Director
- Transaction
- Proposed Sale
- Cost
- $8.75
- #Shares
- 159,478
- Value ($)
- 1,396,230
- #Shares Total
- 0
- Selecky ChristobelJul 01 '26Director
- Transaction
- Option Exercise
- Cost
- $2.99
- #Shares
- 159,478
- Value ($)
- 476,489
- #Shares Total
- 159,478
